Rays of immunity: Role of sunshine vitamin in management of COVID-19 infection and associated comorbidities

Published:September 27, 2021DOI:https://doi.org/10.1016/j.clnesp.2021.09.727

      Summary

      The catastrophic pandemic engendered due to the Novel coronavirus (COVID-19) outbreak which causes severe clinical afflictions on the respiratory system has severely high morbidity and mortality rates. The requirement of novel compounds is at utmost importance due to lack of targeted drug molecule to treat the afflictions and restrict the viral infection and for the usage of prophylactic treatment to avoid the spread of the infection is of utmost importance. Vitamin D is one such naturally available multifunctional molecule, which plays an eminent role in the immune system and instigation of numerous cellular pathways further promoting health benefits and enhancing the human quality of life. This article reviews the current standpoint scenario and future prevalence of vitamin D supplementation in the management of covid-19 patients. Novel findings of Vitamin D suggest that along with regulation of cell growth, neuroprotective and mood-stabilizing effects, it regulates the immune response also modulate cytokine Interleukin-6 (IL-6) by inducing progesterone-induced blocking factor (PIBF), given the IL-6 levels are considerably high in COVID-19 patients which increases the further complications. Vitamin D also have its effect on angiotensin converting enzyme (ACEII) inhibitor through which the COVID-19 virus makes cell entry. Numerous research data elucidate the play of Vitamin D, in complications of COVID-19 including the most common comorbid conditions, neurological manifestations and immunological aspects makes it an ideal molecule for adjuvant therapy. Including Vitamin D as add-on therapy in the management of COVID-19 might aid the arrest of infection and helps fight this arduous epidemic.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Clinical Nutrition ESPEN
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • WHO
        WHO coronavirus (COVID-19) dashboard 2021.
        18-03-2021 (Available from:)
        • Caramelo F.
        • Ferreira N.
        • Oliveiros B.
        Estimation of risk factors for COVID-19 mortality-preliminary results.
        MedRxiv. 2020; https://doi.org/10.1101/2020.02.24.20027268
        • Chang D.
        • Lin M.
        • Wei L.
        • Xie L.
        • Zhu G.
        • Cruz C.S.D.
        • et al.
        Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China.
        JAMA. 2020; 323: 1092-1093
        • Huang C.
        • Wang Y.
        • Li X.
        • Ren L.
        • Zhao J.
        • Hu Y.
        • et al.
        Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
        Lancet. 2020; 395: 497-506
        • Chen N.
        • Zhou M.
        • Dong X.
        • Qu J.
        • Gong F.
        • Han Y.
        • et al.
        Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
        Lancet. 2020; 395: 507-513
        • Wang D.
        • Hu B.
        • Hu C.
        • Zhu F.
        • Liu X.
        • Zhang J.
        • et al.
        Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China.
        JAMA. 2020; 323: 1061-1069
        • Ramiro S.
        • Mostard R.L.M.
        • Magro-Checa C.
        • van Dongen C.M.P.
        • Dormans T.
        • Buijs J.
        • et al.
        Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study.
        Ann Rheum Dis. 2020; 79: 1143-1151
        • Huang M.
        • Tang T.
        • Pang P.
        • Li M.
        • Ma R.
        • Lu J.
        • et al.
        Treating COVID-19 with chloroquine.
        J Mol Cell Biol. 2020; 12: 322-325
        • Li X.
        • Xu S.
        • Yu M.
        • Wang K.
        • Tao Y.
        • Zhou Y.
        • et al.
        Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.
        J Allergy Clin Immunol. 2020; 146: 110-118
        • Duan K.
        • Liu B.
        • Li C.
        • Zhang H.
        • Yu T.
        • Qu J.
        • et al.
        Effectiveness of convalescent plasma therapy in severe COVID-19 patients.
        Proc Natl Acad Sci U S A. 2020; 117: 9490-9496
        • Zeng Q.L.
        • Yu Z.J.
        • Gou J.J.
        • Li G.M.
        • Ma S.H.
        • Zhang G.F.
        • et al.
        Effect of convalescent plasma therapy on viral shedding and survival in patients with coronavirus disease 2019.
        J Infect Dis. 2020; 222: 38-43
        • Doan T.
        • Hinterwirth A.
        • Arzika A.M.
        • Worden L.
        • Chen C.
        • Zhong L.
        • et al.
        Reduction of coronavirus burden with mass azithromycin distribution.
        Clin Infect Dis. 2020; 71: 2282-2284
        • Gautret P.
        • Lagier J.C.
        • Parola P.
        • Hoang V.T.
        • Meddeb L.
        • Mailhe M.
        • et al.
        Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
        Int J Antimicrob Agents. 2020; 56: 105949
        • Xu Y.
        • Baylink D.J.
        • Chen C.S.
        • Reeves M.E.
        • Xiao J.
        • Lacy C.
        • et al.
        The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
        J Transl Med. 2020; 18: 322
        • Hartwell D.
        • Tjellesen L.
        • Christiansen C.
        • Rødbro P.
        Metabolism of vitamin D2 and vitamin D3 in patients on anticonvulsant therapy.
        Acta Neurol Scand. 1989; 79: 487-492
        • Christiansen C.
        • Rødbro P.
        • Sjö O.
        “Anticonvulsant action” of vitamin D in epileptic patients? A controlled pilot study.
        Br Med J. 1974; 2: 258-259
        • Fore H.H.
        • Dongyu Q.
        • Beasley D.M.
        • Ghebreyesus T.A.
        Child malnutrition and COVID-19: the time to act is now.
        Lancet. 2020; 396: 517-518
        • Yu Y.
        • Ye J.
        • Chen M.
        • Jiang C.
        • Lin W.
        • Lu Y.
        • et al.
        Malnutrition prolongs the hospitalization of patients with COVID-19 infection: a clinical epidemiological analysis.
        J Nutr Health Aging. 2021; 25: 369-373
        • WHO
        Malnutrition fact sheet: world health organisation.
        2021 (Available from:)
        • Littlejohn P.
        • Finlay B.B.
        When a pandemic and an epidemic collide: COVID-19, gut microbiota, and the double burden of malnutrition.
        BMC Med. 2021; 19: 31
        • Li T.
        • Zhang Y.
        • Gong C.
        • Wang J.
        • Liu B.
        • Shi L.
        • et al.
        Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China.
        Eur J Clin Nutr. 2020; 74: 871-875
        • Bedock D.
        • Bel Lassen P.
        • Mathian A.
        • Moreau P.
        • Couffignal J.
        • Ciangura C.
        • et al.
        Prevalence and severity of malnutrition in hospitalized COVID-19 patients.
        Clin Nutr ESPEN. 2020; 40: 214-219
        • Handu D.
        • Moloney L.
        • Rozga M.
        • Cheng F.
        Malnutrition care during the COVID-19 pandemic: considerations for registered dietitian nutritionists evidence analysis center.
        J Acad Nutr Diet. 2020; 21: 979-987
        • Fedele D.
        • De Francesco A.
        • Riso S.
        • Collo A.
        Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: an overview.
        Nutrition. 2021; 81: 111016
        • Jovic T.H.
        • Ali S.R.
        • Ibrahim N.
        • Jessop Z.M.
        • Tarassoli S.P.
        • Dobbs T.D.
        • et al.
        Could vitamins help in the fight against COVID-19?.
        Nutrients. 2020; 12
        • Ross A.C.
        • Manson J.E.
        • Abrams S.A.
        • Aloia J.F.
        • Brannon P.M.
        • Clinton S.K.
        • et al.
        The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know.
        J Clin Endocrinol Metab. 2011; 96: 53-58
        • Pludowski P.
        • Holick M.F.
        • Grant W.B.
        • Konstantynowicz J.
        • Mascarenhas M.R.
        • Haq A.
        • et al.
        Vitamin D supplementation guidelines.
        J Steroid Biochem Mol Biol. 2018; 175: 125-135
        • Hollis B.W.
        • Wagner C.L.
        Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant.
        Am J Clin Nutr. 2004; 80 (1752S-8S)
        • Cashman K.D.
        • Dowling K.G.
        • Skrabakova Z.
        • Gonzalez-Gross M.
        • Valtuena J.
        • De Henauw S.
        • et al.
        Vitamin D deficiency in Europe: pandemic?.
        Am J Clin Nutr. 2016; 103: 1033-1044
        • Palacios C.
        • Gonzalez L.
        Is vitamin D deficiency a major global public health problem?.
        J Steroid Biochem Mol Biol. 2014; 144: 138-145
        • Mata-Granados J.M.
        • Luque de Castro M.D.
        • Quesada Gomez J.M.
        Inappropriate serum levels of retinol, alpha-tocopherol, 25 hydroxyvitamin D3 and 24,25 dihydroxyvitamin D3 levels in healthy Spanish adults: simultaneous assessment by HPLC.
        Clin Biochem. 2008; 41: 676-680
        • Grant W.B.
        • Fakhoury H.M.A.
        • Karras S.N.
        • Al Anouti F.
        • Bhattoa H.P.
        Variations in 25-hydroxyvitamin D in countries from the Middle East and Europe: the roles of UVB exposure and diet.
        Nutrients. 2019; 11
        • Boucher B.J.
        The problems of vitamin d insufficiency in older people.
        Aging Dis. 2012; 3: 313
        • Mitchell F.
        Vitamin-D and COVID-19: do deficient risk a poorer outcome?.
        Lancet Diab Endocrinol. 2020; 8
        • Carswell A.T.
        • Oliver S.J.
        • Wentz L.M.
        • Kashi D.S.
        • Roberts R.
        • Tang J.C.Y.
        • et al.
        Influence of vitamin D supplementation by sunlight or oral D3 on exercise performance.
        Med Sci Sports Exerc. 2018; 50: 2555-2564
        • Pereira-Santos M.
        • Costa P.R.
        • Assis A.M.
        • Santos C.A.
        • Santos D.B.
        Obesity and vitamin D deficiency: a systematic review and meta-analysis.
        Obes Rev. 2015; 16: 341-349
        • Feng X.
        • Guo T.
        • Wang Y.
        • Kang D.
        • Che X.
        • Zhang H.
        • et al.
        The vitamin D status and its effects on life quality among the elderly in Jinan, China.
        Arch Gerontol Geriatr. 2016; 62: 26-29
        • Veith R.
        Symposium: optimising vitamin D intake for populations with special needs: barriers to effective food fortification and supplementation. Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards.
        J Nutr. 2006; 136: 1117-1122
        • De Smet D.
        • De Smet K.
        • Herroelen P.
        • Gryspeerdt S.
        • Martens G.A.
        Serum 25(OH)D level on hospital admission associated with COVID-19 stage and mortality.
        Am J Clin Pathol. 2020; 155: 381-388
        • Tan C.W.
        • Ho L.P.
        • Kalimuddin S.
        • Cherng B.P.Z.
        • Teh Y.E.
        • Thien S.Y.
        • et al.
        Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19).
        Nutrition. 2020; 79–80: 111017
        • Castillo M.E.
        • Costa L.M.E.
        • Barrios J.M.V.
        • Díaz J.F.A.
        • Miranda J.L.
        • Bouillon R.
        • et al.
        Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study.
        J Steroid Biochem Mol Biol. 2020; 203: 105751
        • Urashima M.
        • Segawa T.
        • Okazaki M.
        • Kurihara M.
        • Wada Y.
        • Ida H.
        Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren.
        Am J Clin Nutr. 2010; 91: 1255-1260
        • Zhang Y.
        • Fang F.
        • Tang J.
        • Jia L.
        • Feng Y.
        • Xu P.
        • et al.
        Association between vitamin D supplementation and mortality: systematic review and meta-analysis.
        BMJ. 2019; 366: l4673
        • Martineau A.R.
        • Jolliffe D.A.
        • Hooper R.L.
        • Greenberg L.
        • Aloia J.F.
        • Bergman P.
        • et al.
        Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data.
        BMJ. 2017; 356: i6583
        • Jolliffe D.A.
        • Camargo C.A.
        • Sluyter J.D.
        • Aglipay M.
        • Aloia J.F.
        • Ganmaa D.
        • et al.
        Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of aggregate data from randomised controlled trials.
        Lancet Diabetes Endocrinol. 2020; 9: 276-292https://doi.org/10.1016/S2213-8587(21)00051-6
        • Jolliffe D.A.
        • Greenberg L.
        • Hooper R.L.
        • Mathyssen C.
        • Rafiq R.
        • de Jongh R.T.
        • et al.
        Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials.
        Thorax. 2019; 74: 337-345
        • Peng L.
        • Li L.
        • Wang P.
        • Chong W.
        • Li Y.
        • Zha X.
        • et al.
        Association between Vitamin D supplementation and mortality in critically ill patients: a systematic review and meta-analysis of randomized clinical trials.
        PloS One. 2020; 15e0243768
        • Wei Z.
        • Zhang J.
        • Yu X.
        Maternal vitamin D status and childhood asthma, wheeze, and eczema: a systematic review and meta-analysis.
        Pediatr Allergy Immunol. 2016; 27: 612-619
        • Berry D.J.
        • Hesketh K.
        • Power C.
        • Hypponen E.
        Vitamin D status has a linear association with seasonal infections and lung function in British adults.
        Br J Nutr. 2011; 106: 1433-1440
        • Evatt M.L.
        • DeLong M.R.
        • Kumari M.
        • Auinger P.
        • McDermott M.P.
        • Tangpricha V.
        High prevalence of hypovitaminosis D status in patients with early Parkinson disease.
        Arch Neurol. 2011; 68: 314-319
        • Mikati M.
        • Dib L.
        • Yamout B.
        • Sawaya R.
        • Rahi A.
        • Fuleihan G.E.-H.
        Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone.
        Neurology. 2006; 67: 2005-2014
        • Reyes-Garcia R.
        • Mendoza N.
        • Palacios S.
        • Salas N.
        • Quesada-Charneco M.
        • Garcia-Martin A.
        • et al.
        Effects of daily intake of calcium and vitamin D-enriched milk in healthy postmenopausal women: a randomized, controlled, double-blind nutritional study.
        J Womens Health (Larchmt). 2018; 27: 561-568
        • Chung Y.S.
        • Chung D.J.
        • Kang M.I.
        • Kim I.J.
        • Koh J.M.
        • Min Y.K.
        • et al.
        Vitamin D repletion in Korean postmenopausal women with osteoporosis.
        Yonsei Med J. 2016; 57: 923-927
        • Hewison M.
        Vitamin D and innate and adaptive immunity.
        Vitam Horm. 2011; 86: 23-62
        • Grant W.B.
        • Lahore H.
        • McDonnell S.L.
        • Baggerly C.A.
        • French C.B.
        • Aliano J.L.
        • et al.
        Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths.
        Nutrients. 2020; 12
        • Loeb M.
        • Dang A.D.
        • Thiem V.D.
        • Thanabalan V.
        • Wang B.
        • Nguyen N.B.
        • et al.
        Effect of Vitamin D supplementation to reduce respiratory infections in children and adolescents in Vietnam: a randomized controlled trial.
        Influenza Other Respir Viruses. 2019; 13: 176-183
        • Baeke F.
        • Takiishi T.
        • Korf H.
        • Gysemans C.
        • Mathieu C.
        Vitamin D: modulator of the immune system.
        Curr Opin Pharmacol. 2010; 10: 482-496
        • Li-Ng M.
        • Aloia J.F.
        • Pollack S.
        • Cunha B.A.
        • Mikhail M.
        • Yeh J.
        • et al.
        A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections.
        Epidemiol Infect. 2009; 137: 1396-1404
        • Teymoori-Rad M.
        • Shokri F.
        • Salimi V.
        • Marashi S.M.
        The interplay between vitamin D and viral infections.
        Rev Med Virol. 2019; 29e2032
        • Liu P.T.
        • Stenger S.
        • Tang D.H.
        • Modlin R.L.
        Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin.
        J Immunol. 2007; 179: 2060-2063
        • Yang D.
        • Chen Q.
        • Schmidt A.P.
        • Anderson G.M.
        • Wang J.M.
        • Wooters J.
        • et al.
        LL-37, the neutrophil granule–and epithelial cell–derived cathelicidin, utilizes formyl peptide receptor–like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.
        J Exp Med. 2000; 192: 1069-1074
        • Liu P.T.
        • Stenger S.
        • Li H.
        • Wenzel L.
        • Tan B.H.
        • Krutzik S.R.
        • et al.
        Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.
        Science. 2006; 311: 1770-1773
        • Eisenhut M.
        • Shin J.I.
        Pathways in the pathophysiology of coronavirus 19 lung disease accessible to prevention and treatment.
        Front Physiol. 2020; 11: 872
        • Kim J.
        • Yang Y.L.
        • Jang S.H.
        • Jang Y.S.
        Human beta-defensin 2 plays a regulatory role in innate antiviral immunity and is capable of potentiating the induction of antigen-specific immunity.
        Virol J. 2018; 15: 124
        • Castaneda-Delgado J.E.
        • Araujo Z.
        • Gonzalez-Curiel I.
        • Serrano C.J.
        • Rivas Santiago C.
        • Enciso-Moreno J.A.
        • et al.
        Vitamin D and L-isoleucine promote antimicrobial peptide hBD-2 production in peripheral blood mononuclear cells from elderly individuals.
        Int J Vitam Nutr Res. 2016; 86: 56-61
        • Kim J.
        • Yang Y.L.
        • Jeong Y.
        • Jang Y.S.
        Conjugation of human beta-defensin 2 to spike protein receptor-binding domain induces antigen-specific protective immunity against Middle East respiratory syndrome coronavirus infection in human dipeptidyl peptidase 4 transgenic mice.
        Vaccines (Basel). 2020; 8
        • George B.
        • Amjesh R.
        • Paul A.M.
        • Tr S.K.
        • Pillai M.R.
        • Kumar R.
        Evidence of a dysregulated Vitamin D pathway in SARS-CoV-2 infected patient’s lung cells.
        bioRxiv. 2020; https://doi.org/10.1101/2020.12.21.423733
        • Wrzosek M.
        • Łukaszkiewicz J.
        • Wrzosek M.
        • Jakubczyk A.
        • Matsumoto H.
        • Piątkiewicz P.
        • et al.
        Vitamin D and the central nervous system.
        Pharmacol Rep. 2013; 65: 271-278
        • Barrat F.J.
        • Cua D.J.
        • Boonstra A.
        • Richards D.F.
        • Crain C.
        • Savelkoul H.F.
        • et al.
        In vitro generation of interleukin 10–producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)–and Th2-inducing cytokines.
        J Exp Med. 2002; 195: 603-616
        • Xie Z.
        • Chen J.
        • Zheng C.
        • Wu J.
        • Cheng Y.
        • Zhu S.
        • et al.
        1,25-dihydroxyvitamin D3 -induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells.
        Immunology. 2017; 152: 414-424
        • Anand S.P.
        • Selvaraj P.
        Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis.
        Clin Immunol. 2009; 133: 126-131
        • Barna B.P.
        • Malur A.
        • Dalrymple H.
        • Karnekar R.
        • Culver D.A.
        • Abraham S.
        • et al.
        A novel 1,25-dihydroxyvitamin D-activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP).
        Autoimmunity. 2009; 42: 56-62
        • Zheng S.
        • Yang J.
        • Hu X.
        • Li M.
        • Wang Q.
        • Dancer R.C.A.
        • et al.
        Vitamin D attenuates lung injury via stimulating epithelial repair, reducing epithelial cell apoptosis and inhibits TGF-beta induced epithelial to mesenchymal transition.
        Biochem Pharmacol. 2020; 177: 113955
        • Dadaei T.
        • Safapoor M.H.
        • Aghdaei H.A.
        • Balaii H.
        • Pourhoseingholi M.A.
        • Naderi N.
        • et al.
        Effect of vitamin D3 supplementation on TNF-α serum level and disease activity index in Iranian IBD patients.
        Gastroenterol Hepatol Bed to Bench. 2015; 8: 49
        • Shi Y.Y.
        • Liu T.J.
        • Fu J.H.
        • Xu W.
        • Wu L.L.
        • Hou A.N.
        • et al.
        Vitamin D/VDR signaling attenuates lipopolysaccharideinduced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier.
        Mol Med Rep. 2016; 13: 1186-1194
        • Kong J.
        • Zhu X.
        • Shi Y.
        • Liu T.
        • Chen Y.
        • Bhan I.
        • et al.
        VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system.
        Mol Endocrinol. 2013; 27: 2116-2125
        • Tsujino I.
        • Ushikoshi-Nakayama R.
        • Yamazaki T.
        • Matsumoto N.
        • Saito I.
        Pulmonary activation of vitamin D3 and preventive effect against interstitial pneumonia.
        J Clin Biochem Nutr. 2019; 65: 245-251
        • Fernandez-Robredo P.
        • González-Zamora J.
        • Recalde S.
        • Bilbao-Malavé V.
        • Bezunartea J.
        • Hernandez M.
        • et al.
        Vitamin D protects against oxidative stress and inflammation in human retinal cells.
        Antioxidants. 2020; 9: 838
        • Gal-Tanamy M.
        • Bachmetov L.
        • Ravid A.
        • Koren R.
        • Erman A.
        • Tur-Kaspa R.
        • et al.
        Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes.
        Hepatology. 2011; 54: 1570-1579
        • Farnik H.
        • Bojunga J.
        • Berger A.
        • Allwinn R.
        • Waidmann O.
        • Kronenberger B.
        • et al.
        Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients.
        Hepatology. 2013; 58: 1270-1276
        • Mowry E.M.
        • James J.A.
        • Krupp L.B.
        • Waubant E.
        Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis.
        Mult Scler. 2011; 17: 666-671
        • Rosjo E.
        • Lossius A.
        • Abdelmagid N.
        • Lindstrom J.C.
        • Kampman M.T.
        • Jorgensen L.
        • et al.
        Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.
        Mult Scler. 2017; 23: 395-402
        • Chao C.T.
        • Lee S.Y.
        • Yang W.S.
        • Yen C.J.
        • Chiang C.K.
        • Huang J.W.
        • et al.
        Serum vitamin D levels are positively associated with varicella zoster immunity in chronic dialysis patients.
        Sci Rep. 2014; 4: 7371
        • Chadha M.K.
        • Fakih M.
        • Muindi J.
        • Tian L.
        • Mashtare T.
        • Johnson C.S.
        • et al.
        Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients.
        Prostate. 2011; 71: 368-372
        • Mandorfer M.
        • Reiberger T.
        • Payer B.A.
        • Ferlitsch A.
        • Breitenecker F.
        • Aichelburg M.C.
        • et al.
        Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.
        AIDS. 2013; 27: 227-232
        • Yancheva N.
        • Elenkov I.
        • Tchervenyakova T.
        • Gabarska I.
        • Kirilov G.
        • Nikolova M.
        • et al.
        Deficiency of vitamin D in HIV infected patients and its effect on some of the immunological parameters.
        World J AIDS. 2015; 5: 182-188
        • Khare D.
        • Godbole N.M.
        • Pawar S.D.
        • Mohan V.
        • Pandey G.
        • Gupta S.
        • et al.
        Calcitriol [1, 25[OH]2 D3] pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells.
        Eur J Nutr. 2013; 52: 1405-1415
        • Campbell G.R.
        • Spector S.A.
        Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy.
        PLoS Pathog. 2012; 8e1002689
        • Goncalves-Mendes N.
        • Talvas J.
        • Duale C.
        • Guttmann A.
        • Corbin V.
        • Marceau G.
        • et al.
        Impact of vitamin D supplementation on influenza vaccine response and immune functions in deficient elderly persons: a randomized placebo-controlled trial.
        Front Immunol. 2019; 10: 65
        • Yamshchikov A.V.
        • Desai N.S.
        • Blumberg H.M.
        • Ziegler T.R.
        • Tangpricha V.
        Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials.
        Endocr Pract. 2009; 15: 438-449
        • Rastogi A.
        • Bhansali A.
        • Khare N.
        • Suri V.
        • Yaddanapudi N.
        • Sachdeva N.
        • et al.
        Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study).
        Postgrad Med J. 2020; : 1-4
        • Bjelakovic G.
        • Gluud L.L.
        • Nikolova D.
        • Whitfield K.
        • Wetterslev J.
        • Simonetti R.G.
        • et al.
        Vitamin D supplementation for prevention of mortality in adults.
        Cochrane Database Syst Rev. 2014;
        • Santaolalla A.
        • Beckmann K.
        • Kibaru J.
        • Josephs D.
        • Van Hemelrijck M.
        • Irshad S.
        Association between vitamin D and novel SARS-CoV-2 respiratory dysfunction - a scoping review of current evidence and its implication for COVID-19 pandemic.
        Front Physiol. 2020; 11: 564387
        • Laird E.
        • Rhodes J.
        • Kenny R.A.
        Vitamin D and inflammation: potential implications for severity of Covid-19.
        Ir Med J. 2020; 113: 81
        • D'Avolio A.
        • Avataneo V.
        • Manca A.
        • Cusato J.
        • De Nicolo A.
        • Lucchini R.
        • et al.
        25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2.
        Nutrients. 2020; 12
        • Kaufman H.W.
        • Niles J.K.
        • Kroll M.H.
        • Bi C.
        • Holick M.F.
        SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels.
        PloS One. 2020; 15e0239252
        • Padhi S.
        • Suvankar S.
        • Panda V.K.
        • Pati A.
        • Panda A.K.
        Lower levels of vitamin D are associated with SARS-CoV-2 infection and mortality in the Indian population: an observational study.
        Int Immunopharmacol. 2020; 88: 107001
        • Radujkovic A.
        • Hippchen T.
        • Tiwari-Heckler S.
        • Dreher S.
        • Boxberger M.
        • Merle U.
        Vitamin D deficiency and outcome of COVID-19 patients.
        Nutrients. 2020; 12
        • Annweiler C.
        • Hanotte B.
        • Grandin de l'Eprevier C.
        • Sabatier J.M.
        • Lafaie L.
        • Celarier T.
        Vitamin D and survival in COVID-19 patients: a quasi-experimental study.
        J Steroid Biochem Mol Biol. 2020; 204: 105771
        • Pereira M.
        • Dantas Damascena A.
        • Galvao Azevedo L.M.
        • de Almeida Oliveira T.
        • da Mota Santana J.
        Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis.
        Crit Rev Food Sci Nutr. 2020; : 1-9
        • Munshi R.
        • Hussein M.H.
        • Toraih E.A.
        • Elshazli R.M.
        • Jardak C.
        • Sultana N.
        • et al.
        Vitamin D insufficiency as a potential culprit in critical COVID-19 patients.
        J Med Virol. 2021; 93: 733-740
        • Huang F.
        • Zhang C.
        • Liu Q.
        • Zhao Y.
        • Zhang Y.
        • Qin Y.
        • et al.
        Identification of amitriptyline HCl, flavin adenine dinucleotide, azacitidine and calcitriol as repurposing drugs for influenza A H5N1 virus-induced lung injury.
        PLoS Pathog. 2020; 16e1008341
      1. Sierra B. Pérez A.B. Aguirre E. Bracho C. Valdés O. Jimenez N. Association of early nasopharyngeal immune markers with COVID-19 clinical outcome: predictive value of CCL2/MCP-1. Open forum infectious diseases. Oxford University Press US, 2020
        • Anderberg S.B.
        • Luther T.
        • Berglund M.
        • Larsson R.
        • Rubertsson S.
        • Lipcsey M.
        • et al.
        Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
        Cytokine. 2021; 138: 155389
        • Omidian M.
        • Mahmoudi M.
        • Javanbakht M.H.
        • Eshraghian M.R.
        • Abshirini M.
        • Daneshzad E.
        • et al.
        Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: a randomized, placebo-controlled, double-blind clinical trial.
        Diabetes Metab Syndr. 2019; 13: 2873-2877
        • Miroliaee A.E.
        • Salamzadeh J.
        • Shokouhi S.
        • Sahraei Z.
        The study of vitamin D administration effect on CRP and Interleukin-6 as prognostic biomarkers of ventilator associated pneumonia.
        J Crit Care. 2018; 44: 300-305
        • Arya A.
        • Dwivedi V.D.
        Synergistic effect of vitamin D and remdesivir can fight COVID-19.
        J Biomol Struct Dyn. 2020; : 1-2
        • Bassatne A.
        • Basbous M.
        • Chakhtoura M.
        • El Zein O.
        • Rahme M.
        • Fuleihan G.E.
        The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis.
        Metabolism. 2021 Mar 24; : 154753
        • Kazemi A.
        • Mohammadi V.
        • Aghababaee S.K.
        • Golzarand M.
        • Clark C.C.
        • Babajafari S.
        Association of vitamin D status with SARS-CoV-2 infection or COVID-19 severity: a systematic review and meta-analysis.
        Adv Nutr. 2021 Mar 5; 12: 2040
        • Akbar M.R.
        • Wibowo A.
        • Pranata R.
        • Setiabudiawan B.
        Low serum 25-hydroxyvitamin D (vitamin D) level is associated with susceptibility to COVID-19, severity, and mortality: a systematic review and meta-analysis.
        Front Nutr. 2021 Mar 29; 8: 131
        • Rousseau A.
        Effect of vitamin D on hospitalized adults with COVID-19 infection - full text view - ClinicalTrials.gov.
        2021 ([online] Clinicaltrials.gov. Available at:)
        • Manson J.
        Vitamin D and COVID-19 trial - full text view - ClinicalTrials.gov.
        2021 ([online] Clinicaltrials.gov. Available at:)
        https://clinicaltrials.gov/ct2/show/NCT04536298
        Date accessed: September 3, 2021
        • Li B.
        • Yang J.
        • Zhao F.
        • Zhi L.
        • Wang X.
        • Liu L.
        • et al.
        Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.
        Clin Res Cardiol. 2020; 109: 531-538
        • Wang D.
        • Hu B.
        • Hu C.
        • Zhu F.
        • Liu X.
        • Zhang J.
        • et al.
        Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China.
        JAMA. 2020; 323: 1061-1069
        • Zhou F.
        • Yu T.
        • Du R.
        • Fan G.
        • Liu Y.
        • Liu Z.
        • et al.
        Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
        Lancet. 2020; 395: 1054-1062
        • Mehra M.R.
        • Ruschitzka F.
        COVID-19 illness and heart failure: a missing link?.
        JACC Heart Fail. 2020; 8: 512-514
        • de Lucena T.M.C.
        • da Silva Santos A.F.
        • de Lima B.R.
        • de Albuquerque Borborema M.E.
        • de Azevedo Silva J.
        Mechanism of inflammatory response in associated comorbidities in COVID-19.
        Diabetes Metab Syndr. 2020; 14: 597-600
        • Oudit G.Y.
        • Zhong J.
        • Basu R.
        • Guo D.
        • Penninger J.M.
        • Kassiri Z.
        Angiotensin converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis and diastolic dysfunction.
        J Card Fail. 2010; 16
        • Patel V.B.
        • Zhong J.-C.
        • Grant M.B.
        • Oudit G.Y.
        Role of the ACE2/angiotensin 1–7 axis of the renin–angiotensin system in heart failure.
        Circ Res. 2016; 118: 1313-1326
        • Hoffmann M.
        • Kleine-Weber H.
        • Schroeder S.
        • Kruger N.
        • Herrler T.
        • Erichsen S.
        • et al.
        SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.
        Cell. 2020; 181: 271-280 e8
        • Boulle A.
        • Davies M.-A.
        • Hussey H.
        • Ismail M.
        • Morden E.
        • Vundle Z.
        • et al.
        Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa.
        Clin Infect Dis: Offic Publ Inf Dis Soc Am. 2020; https://doi.org/10.1093/cid/ciaa1198
        • Su H.
        • Yang M.
        • Wan C.
        • Yi L.X.
        • Tang F.
        • Zhu H.Y.
        • et al.
        Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China.
        Kidney Int. 2020; 98: 219-227
        • Wolden-Kirk H.
        • Overbergh L.
        • Gysemans C.
        • Brusgaard K.
        • Naamane N.
        • Van Lommel L.
        • et al.
        Unraveling the effects of 1,25OH2D3 on global gene expression in pancreatic islets.
        J Steroid Biochem Mol Biol. 2013; 136: 68-79
        • Szymczak-Pajor I.
        • Sliwinska A.
        Analysis of association between vitamin D deficiency and insulin resistance.
        Nutrients. 2019; 11
        • Altieri B.
        • Grant W.B.
        • Della Casa S.
        • Orio F.
        • Pontecorvi A.
        • Colao A.
        • et al.
        Vitamin D and pancreas: the role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer.
        Crit Rev Food Sci Nutr. 2017; 57: 3472-3488
        • Norman A.W.
        • Frankel J.
        • Heldt A.M.
        • Grodsky G.M.
        Vitamin D deficiency inhibits pancreatic secretion of insulin.
        Science. 1980; 209: 823-825
        • Koyama T.
        • Shibakura M.
        • Ohsawa M.
        • Kamiyama R.
        • Hirosawa S.
        Anticoagulant effects of 1α,25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes.
        Blood. 1998; 92: 160-167
        • Hoang M.P.
        • Kanjanaumporn J.
        • Aeumjaturapat S.
        • Chusakul S.
        • Seresirikachorn K.
        • Snidvongs K.
        Olfactory and gustatory dysfunctions in COVID-19 patients: a systematic review and meta-analysis.
        Asian Pac J Allergy Immunol. 2020; 38: 162-169
        • Lechien J.R.
        • Chiesa-Estomba C.M.
        • De Siati D.R.
        • Horoi M.
        • Le Bon S.D.
        • Rodriguez A.
        • et al.
        Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.
        Eur Arch Otorhinolaryngol. 2020; 277: 2251-2261
        • Hung E.C.
        • Chim S.S.
        • Chan P.K.
        • Tong Y.K.
        • Ng E.K.
        • Chiu R.W.
        • et al.
        Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome.
        Clin Chem. 2003; 49: 2108
        • Mao L.
        • Jin H.
        • Wang M.
        • Hu Y.
        • Chen S.
        • He Q.
        • et al.
        Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in wuhan, China.
        JAMA Neurol. 2020; 77: 683-690
        • Montalvan V.
        • Lee J.
        • Bueso T.
        • De Toledo J.
        • Rivas K.
        Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review.
        Clin Neurol Neurosurg. 2020; 194: 105921
        • Correia A.O.
        • Feitosa P.W.G.
        • Moreira J.L.S.
        • Nogueira S.A.R.
        • Fonseca R.B.
        • Nobre M.E.P.
        Neurological manifestations of COVID-19 and other coronaviruses: a systematic review.
        Neurol Psychiatry Brain Res. 2020; 37: 27-32
        • Chu H.
        • Chan J.F.-W.
        • Yuen T.T.-T.
        • Shuai H.
        • Yuan S.
        • Wang Y.
        • et al.
        Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study.
        Lancet Microbe. 2020; 1: e14-e23
        • Chen R.
        • Wang K.
        • Yu J.
        • Howard D.
        • French L.
        • Chen Z.
        • et al.
        The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains.
        Front Neurol. 2021; 11: 1860
        • Kabbani N.
        • Olds J.L.
        Does COVID19 infect the brain? If so, smokers might Be at a higher risk.
        Mol Pharmacol. 2020; 97: 351-353
        • Zhang B.Z.
        • Chu H.
        • Han S.
        • Shuai H.
        • Deng J.
        • Hu Y.F.
        • et al.
        SARS-CoV-2 infects human neural progenitor cells and brain organoids.
        Cell Res. 2020; 30: 928-931
        • Lin M.
        • Gao P.
        • Zhao T.
        • He L.
        • Li M.
        • Li Y.
        • et al.
        Calcitriol regulates angiotensin-converting enzyme and angiotensin converting-enzyme 2 in diabetic kidney disease.
        Mol Biol Rep. 2016; 43: 397-406
        • Malek Mahdavi A.
        A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: implications for a potential treatment for COVID-19.
        Rev Med Virol. 2020; 30: e2119
        • Hollo A.
        • Clemens Z.
        • Kamondi A.
        • Lakatos P.
        • Szucs A.
        Correction of vitamin D deficiency improves seizure control in epilepsy: a pilot study.
        Epilepsy Behav. 2012; 24: 131-133
        • Parsons T.
        • Banks S.
        • Bae C.
        • Gelber J.
        • Alahmadi H.
        • Tichauer M.
        COVID-19-associated acute disseminated encephalomyelitis (ADEM).
        J Neurol. 2020; 267: 2799-2802
        • Lemire J.M.
        • Archer D.C.
        1, 25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis.
        J Clin Invest. 1991; 87: 1103-1107
        • Cantorna M.T.
        • Hayes C.E.
        • DeLuca H.F.
        1, 25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis.
        Proc Natl Acad Sci Unit States Am. 1996; 93: 7861-7864
        • Neveu I.
        • Naveilhan P.
        • Baudet C.
        • Wion D.
        • De Luca H.F.
        • Brachet P.
        1, 25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells.
        Mol Brain Res. 1994; 24: 70-76
        • Khairy E.Y.
        • Attia M.M.
        Protective effects of vitamin D on neurophysiologic alterations in brain aging: role of brain-derived neurotrophic factor (BDNF).
        Nutr Neurosci. 2019; : 1-10
        • Pertile R.A.N.
        • Cui X.
        • Hammond L.
        • Eyles D.W.
        Vitamin D regulation of GDNF/Ret signaling in dopaminergic neurons.
        FASEB J. 2018; 32: 819-828
        • Netland J.
        • Meyerholz D.K.
        • Moore S.
        • Cassell M.
        • Perlman S.
        Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2.
        J Virol. 2008; 82: 7264-7275
        • Gomez-Pinedo U.
        • Cuevas J.A.
        • Benito-Martin M.S.
        • Moreno-Jimenez L.
        • Esteban-Garcia N.
        • Torre-Fuentes L.
        • et al.
        Vitamin D increases remyelination by promoting oligodendrocyte lineage differentiation.
        Brain Behav. 2020; 10e01498
        • Nataf S.
        An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19.
        J Med Virol. 2020; 92: 1743-1744
        • Grant W.B.
        • Cross H.S.
        • Garland C.F.
        • Gorham E.D.
        • Moan J.
        • Peterlik M.
        • et al.
        Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe.
        Prog Biophys Mol Biol. 2009 Feb 1; 99: 104-113
        • Grant W.B.
        • Schwalfenberg G.K.
        • Genuis S.J.
        • Whiting S.J.
        An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada.
        Mol Nutr Food Res. 2010 Aug; 54: 1172-1181
        • Forman J.P.
        • Giovannucci E.
        • Holmes M.D.
        • Bischoff-Ferrari H.A.
        • Tworoger S.S.
        • Willett W.C.
        • et al.
        Plasma 25-hydroxyvitamin D levels and risk of incident hypertension.
        Hypertension. 2007 May 1; 49: 1063-1069
        • Brøndum-Jacobsen P.
        • Benn M.
        • Jensen G.B.
        • Nordestgaard B.G.
        25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies.
        Arterioscler Thromb Vasc Biol. 2012 Nov; 32: 2794-2802
        • Holick M.F.
        Vitamin D deficiency.
        N Engl J Med. 2007 Jul 19; 357: 266-281
        • Khademvatani K.
        • Seyyed-Mohammadzad M.H.
        • Akbari M.
        • Rezaei Y.
        • Eskandari R.
        • Rostamzadeh A.
        The relationship between vitamin D status and idiopathic lower-extremity deep vein thrombosis.
        Int J Gen Med. 2014; 7: 303
        • Wu W.X.
        • He D.R.
        Low vitamin D levels are associated with the development of deep venous thromboembolic events in patients with ischemic stroke.
        Clin Appl Thromb Hemost. 2018 Dec; 24: 69S-75S
        • Blondon M.
        • Rodabough R.J.
        • Budrys N.
        • Johnson K.C.
        • Berger J.S.
        • Shikany J.M.
        • et al.
        The effect of calcium plus vitamin D supplementation on the risk of venous thromboembolism.
        Thromb Haemostasis. 2015 Sep; 113: 999-1009
        • Mohammad S.
        • Mishra A.
        • Ashraf M.Z.
        Emerging role of vitamin D and its associated molecules in pathways related to pathogenesis of thrombosis.
        Biomolecules. 2019 Nov; 9: 649
        • Al-Daghri N.M.
        • Alokail M.S.
        • Manousopoulou A.
        • Heinson A.
        • Al-Attas O.
        • Al-Saleh Y.
        • et al.
        Sex-specific vitamin D effects on blood coagulation among overweight adults.
        Eur J Clin Invest. 2016 Dec; 46: 1031-1040
        • Zhang Y.
        • He L.
        • Chen H.
        • Lu S.
        • Xiong Y.
        • Liu J.
        • et al.
        Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: retrospective analysis.
        Int J Lab Hematol. 2020 Dec; 42: 766-772
        • Hirsch D.
        • Archer F.E.
        • Joshi-Kale M.
        • Vetrano A.M.
        • Weinberger B.
        Decreased anti-inflammatory responses to vitamin D in neonatal neutrophils.
        Mediat Inflamm. 2011 Oct; 2011: 7https://doi.org/10.1155/2011/598345
        • Koyama T.
        • Shibakura M.
        • Ohsawa M.
        • Kamiyama R.
        • Hirosawa S.
        Anticoagulant effects of 1α, 25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes.
        Blood J Am Soc Hematol. 1998 Jul 1; 92: 160-167
        • Hyppönen E.
        • Berry D.
        • Cortina-Borja M.
        • Power C.
        25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort.
        PloS One. 2010 May 24; 5e10801
        • di Filippo L.
        • Frara S.
        • Giustina A.
        The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects.
        Nat Rev Endocrinol. 2021 Jun 2; : 1-2
        • Martha J.W.
        • Wibowo A.
        • Pranata R.
        Hypocalcemia is associated with severe COVID-19: a systematic review and meta-analysis.
        Diab Metabol Syndr: Clin Res Rev. 2021 Jan 18; 15: 337-342
        • di Filippo L.
        • Doga M.
        • Frara S.
        • Giustina A.
        Hypocalcemia in COVID-19: prevalence, clinical significance and therapeutic implications.
        Rev Endocr Metab Disord. 2021 Apr 13; (1-0)https://doi.org/10.1007/s11154-021-09655-z
        • di Filippo L.
        • Formenti A.M.
        • Doga M.
        • Frara S.
        • Rovere-Querini P.
        • Bosi E.
        • et al.
        Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients.
        Endocrine. 2021 Jan; 71: 9-13
        • Zhou Y.
        • Frey T.K.
        • Yang J.J.
        Viral calciomics: interplays between Ca2+ and virus.
        Cell Calcium. 2009 Jul 1; 46: 1-7
        • Liu J.
        • Han P.
        • Wu J.
        • Gong J.
        • Tian D.
        Prevalence and predictive value of hypocalcemia in severe COVID-19 patients.
        J Inf Publ Health. 2020 Sep 1; 13: 1224-1228
        • Bhraonáin S.N.
        • Lawton L.D.
        Chronic malnutrition may in fact be an acute emergency.
        J Emerg Med. 2013 Jan 1; 44: 72-74